At the conclusion of a challenging 2020, we at the Society for Vascular Surgery (SVS) have a clear mission ahead: We must work with the U.S. Congress to avoid what military experts refer to as a “tragedy of the unprepared.”
New pocket guides of the Society for Vascular Surgery (SVS) clinical practice guidelines and reporting standards are now available, with printed guides sent to all members.
The Quality Council has earmarked a major initiative for 2021, and it will involve sponsorship of the first official set of SVS Appropriate Use Criteria guidelines, focusing on claudication.
The Quality and Performance Measures Committee (QPMC) is tasked with monitoring and creating national performance measures that are relevant to vascular surgeons.
The SVS Communications Committee, equipped with three subcommittees, is a new addition for 2021.
The SVS Appointments Committee has made great efforts to be more transparent, diverse and equitable in recent years—a process its chair and members plan to continue.
Among the many projects of the SVS Coding and Reimbursement Committee, advocating appropriate coverage for vascular services continues to be a major focus. In 2021, the committee, led by chair Sunita Srivastava, MD, will continue to increase its coverage initiatives, working with government and private payers.
A grant from the SVS Foundation has helped amputees in the Fresno, Calif. area get up and walking more quickly than is typical.
The below are the references for the article about research opportunities within the Department of Veterans Affairs, which ran in the December 2020 Specialist.
The last nine months took away much. The Vascular Annual Meeting (VAM) was canceled. The Vascular Research Initiatives Conference (VRIC) suffered a similar fate—its content latterly resuscitated in virtual form last month. The traditional Society for Vascular Surgery (SVS) presidential handover, too, followed an unorthodox route.
Psychologists place great emphasis on the object permanence milestone, but object impermanence is the more brutal lesson. My experience is now familiar and commonplace. Hundreds of thousands of Americans have lost a parent during the pandemic. Our usual methods of closure have been stripped from us. People are dying in isolation, and the ones they leave behind must often grieve alone. Our failure to control the pandemic has had profound psychological consequences beyond the endless death toll. Our country has risen to similar challenges before, and I believe it will again if we learn from the mistakes we made this year. To accomplish this, we must create a complete account of the costs we have endured.
Humans are social animals, and, over time, they have found that their best times are spent in groups. We have just celebrated Thanksgiving, spending time with our most important group, our family, reflecting on our present life situation and giving thanks. And more holidays are to come.
Applications for three Society for Vascular Surgery (SVS) Foundation awards are coming up early in the new year.
The low rate of events that occur in small abdominal aortic aneurysms (AAAs) supports the continuance of ultrasound surveillance every three years for those that measure between 3–3.9 cm and every year for those 4–4.9cm, researchers found.
Though many individual components will remain the same, the 2021 Vascular Annual Meeting (VAM) will have a different look and feel.
A gift to the SVS Foundation funds not just things—patient education fliers, research awards and community awareness projects—but also hope for a better future.
The Society for Vascular Surgery (SVS) has launched three new mobile apps to help guide surgeons in the treatment and management of chronic limb-threatening ischemia (CLTI).
The American Medical Association's Board of Trustees has named Society for Vascular Surgery (SVS) longtime coding expert and member Robert M. Zwolak, MD, as the AMA alternative representative to the organization’s RVS Update Committee (RUC), and alternative vice chair.
The Society for Vascular Surgery would like to welcome the popular Audible Bleeding podcast into its communications family.
During the virtual annual meeting of the New England Society for Vascular Surgery (NESVS), outgoing president Marc L. Schermerhorn, MD, called for the NESVS to follow the lead of the Society for Vascular Surgery (SVS) by creating a diversity task force.
ROSEMONT, ILL, Nov. 18, 2020 – The Society for Vascular Surgery introduces three new mobile apps to guide surgeons in the treatment and management of Chronic Limb-Threatening Ischemia (CLTI).
Will you give on Giving Tuesday? This will be the SVS Foundation’s third year marking the annual global day of giving— Dec. 1, this year—which follows Thanksgiving and the big shopping days of Black Friday and Cyber Monday.
The vascular system is like the highway of the body – composed of blood vessels including arteries, veins and capillaries. Vascular disease is any condition of the almost 100,000 miles of blood vessels in the body; any complication along this highway can cause problems and health risk. In most cases, however, vascular conditions are highly treatable, often without surgery. Two common vein conditions include spider veins and varicose veins, but what are the differences?
Vascular surgeons are being encouraged to take consideration of a set of talking points about the risks and benefits of paclitaxel-equipped devices—developed by a multispecialty panel of medical societies—in discussions with their patients.
Continuing resolution to fund the government disregards need to protect patient access to care.
FOR IMMEDIATE RELEASE
Media Contact
Beth Richman
brichman1@gmail.com
312-806-8999
Findings Reinforce Vascular Surgeons’ Value for Trauma Centers
The Society for Vascular Surgery (SVS) urges Congress to stop the harmful Medicare cuts that will take effect in less than two months and will limit patient access to needed care; Majority of the U.S. House supports stopping the cuts.
Organizations representing more than one million physician and non-physician health care providers unite to protect care for the millions of seniors who rely on the Medicare program.
A large single-center retrospective study reveals the risk of acute kidney injury (AKI) following pharmacomechanical thrombolysis (PMT) for lower extremity deep vein thrombosis (DVT) is a high as 22%.
The Society for Vascular Surgery (SVS) has released updated clinical practice guidelines accompanied by an implementation document on the management of patients with extracranial carotid artery disease. Since stroke prevention related to carotid artery disease is of major interest to vascular surgeons, the documents aim to use the existing clinical evidence to ensure patients with atherosclerotic occlusive disease in the carotid arteries receive appropriate treatment and care.
The Society for Vascular Surgery (SVS) has released a new clinical practice guideline to ensure that patients with aneurysms of the popliteal arteries (located behind the knee) receive appropriate treatment and care. Aneurysms of the popliteal artery are the most common aneurysms outside of the brain and abdominal aorta.
Further stratification according to preprocedural symptoms in patients undergoing transfemoral carotid artery stenting (TFCAS) improves the preoperative risk assessment, a review of the Society of Vascular Surgery’s Vascular Quality Initiative (VQI) data suggests.
The Society for Vascular Surgery (SVS), the leading not-for-profit, professional medical society on establishing causes and treatments for vascular disease, today announced its officers for 2021-2022. Several officers shifted roles and Dr. Joseph L. Mills was elected vice president at the SVS annual business meeting held virtually on June 16, 2021.
Over the course of the last year, the Society for Vascular Surgery (SVS) has been on a journey toward fostering greater diversity, equity and inclusion (DEI). From the nadir of #Medbikini almost a year ago, the SVS Executive Board has since embraced and published a report from the SVS DEI Task Force—now a full-fledged committee—that called for action and change.
“What do you mean your partner? Does that mean a man?” These were among the questions one of my mentors asked me when we were discussing my list of pros and cons regarding the vascular surgery residency training programs to which I would apply. “Yes, my partner is a man.” The expected “oh…” was a reply I heard going to research meetings and throughout the residency interview trail. Unclear was whether this “oh” was one of disappointment, a nervous response, or concern if I would “fit” in vascular surgery. This “oh” haunts me because, in one short utterance, all of my accomplishments can be easily stripped away.
This year, the two major meetings of the Society for Vascular Surgery (SVS) that involve the presentation of scientific research are being housed in one tent. The Vascular Research Initiatives Conference (VRIC), typically held in May and geared to translational research, will be held over two sessions Thursday and Friday at the 2021 Vascular Annual Meeting (VAM). More than 25 abstracts will be presented in four sessions covering arterial remodeling and discovery science for venous disease; vascular regeneration, stem cells and wound healing; atherosclerosis and the role of the immune system; and aortopathies and novel vascular devices.
While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When covid hit, it intensified our focus on what was truly important: our members, their patients and the SVS as their Society,” said Executive Director Kenneth M. Slaw, PhD. “That focus was sustained the past 15 months and it has led to innovation and an unprecedented volume of member value programs.” He outlined important highlights from the fiscal year that ended March 31—just more than a year after the pandemic was declared—and the vital initiatives that continue to move forward.
Continuing resolution to fund the government disregards need to protect patient access to care.
FOR IMMEDIATE RELEASE
Media Contact
Beth Richman
brichman1@gmail.com
312-806-8999
Findings Reinforce Vascular Surgeons’ Value for Trauma Centers
The Society for Vascular Surgery (SVS) urges Congress to stop the harmful Medicare cuts that will take effect in less than two months and will limit patient access to needed care; Majority of the U.S. House supports stopping the cuts.
Organizations representing more than one million physician and non-physician health care providers unite to protect care for the millions of seniors who rely on the Medicare program.
A large single-center retrospective study reveals the risk of acute kidney injury (AKI) following pharmacomechanical thrombolysis (PMT) for lower extremity deep vein thrombosis (DVT) is a high as 22%.
The Society for Vascular Surgery (SVS) has released updated clinical practice guidelines accompanied by an implementation document on the management of patients with extracranial carotid artery disease. Since stroke prevention related to carotid artery disease is of major interest to vascular surgeons, the documents aim to use the existing clinical evidence to ensure patients with atherosclerotic occlusive disease in the carotid arteries receive appropriate treatment and care.
The Society for Vascular Surgery (SVS) has released a new clinical practice guideline to ensure that patients with aneurysms of the popliteal arteries (located behind the knee) receive appropriate treatment and care. Aneurysms of the popliteal artery are the most common aneurysms outside of the brain and abdominal aorta.
Further stratification according to preprocedural symptoms in patients undergoing transfemoral carotid artery stenting (TFCAS) improves the preoperative risk assessment, a review of the Society of Vascular Surgery’s Vascular Quality Initiative (VQI) data suggests.
The Society for Vascular Surgery (SVS), the leading not-for-profit, professional medical society on establishing causes and treatments for vascular disease, today announced its officers for 2021-2022. Several officers shifted roles and Dr. Joseph L. Mills was elected vice president at the SVS annual business meeting held virtually on June 16, 2021.
Over the course of the last year, the Society for Vascular Surgery (SVS) has been on a journey toward fostering greater diversity, equity and inclusion (DEI). From the nadir of #Medbikini almost a year ago, the SVS Executive Board has since embraced and published a report from the SVS DEI Task Force—now a full-fledged committee—that called for action and change.
“What do you mean your partner? Does that mean a man?” These were among the questions one of my mentors asked me when we were discussing my list of pros and cons regarding the vascular surgery residency training programs to which I would apply. “Yes, my partner is a man.” The expected “oh…” was a reply I heard going to research meetings and throughout the residency interview trail. Unclear was whether this “oh” was one of disappointment, a nervous response, or concern if I would “fit” in vascular surgery. This “oh” haunts me because, in one short utterance, all of my accomplishments can be easily stripped away.
This year, the two major meetings of the Society for Vascular Surgery (SVS) that involve the presentation of scientific research are being housed in one tent. The Vascular Research Initiatives Conference (VRIC), typically held in May and geared to translational research, will be held over two sessions Thursday and Friday at the 2021 Vascular Annual Meeting (VAM). More than 25 abstracts will be presented in four sessions covering arterial remodeling and discovery science for venous disease; vascular regeneration, stem cells and wound healing; atherosclerosis and the role of the immune system; and aortopathies and novel vascular devices.
While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When covid hit, it intensified our focus on what was truly important: our members, their patients and the SVS as their Society,” said Executive Director Kenneth M. Slaw, PhD. “That focus was sustained the past 15 months and it has led to innovation and an unprecedented volume of member value programs.” He outlined important highlights from the fiscal year that ended March 31—just more than a year after the pandemic was declared—and the vital initiatives that continue to move forward.